AbbVie Reports Q2 2024 Financial Performance: Revenue Increases but Profits Drop
Thursday, 25 July 2024, 11:52
AbbVie Q2 2024 Financial Overview
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) has released its financial results for the second quarter of 2024. While the company reported an increase in revenues, there was a significant decline in adjusted earnings.
Key Financial Metrics
- Worldwide Net Revenues: $14.46 billion
- Revenue Growth: Up 4.3% year-over-year
- Adjusted Earnings: Decreased compared to previous quarters
The results exceeded market projections, highlighting the company's ability to generate sales growth. However, the drop in adjusted profits raises concerns about long-term profitability amidst ongoing industry challenges.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.